Prosecution Insights
Prosecution Insights
9 pending office actions • 6 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (33%) |
| §102 only | 2 (22%) |
| §112 only | 2 (22%) |
| Double-patenting only | 1 (11%) |
| Double-patenting + other | 1 (11%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WESTON, ALYSSA G | 2 | 60.0% | +51.3% |
| DUFFY, BRADLEY | 1 | 54.6% | +45.5% |
| KELLY, ROBERT M | 1 | 73.8% | +24.8% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.0% | +16.2% |
| LEONARD, ARTHUR S | 1 | 50.9% | +50.5% |
| SHIN, DANA H | 1 | 27.0% | +27.4% |
| DHAR, MATASHA | 1 | 43.8% | +47.5% |
| GANGLE, BRIAN J | 1 | 76.6% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924345 | METHOD | SHIN, DANA H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18158310 | CELL | LEONARD, ARTHUR S | 18d overdue |
| 18597357 | CHIMERIC ANTIGEN RECEPTOR | DUFFY, BRADLEY | — |
| 18590698 | NUCLEIC ACID CONSTRUCT | KELLY, ROBERT M | — |
| 18504554 | VECTORS | KINSEY WHITE, NICOLE ERIN | — |
| 17924345 | METHOD | SHIN, DANA H | — |
| 17915637 | CELL | DHAR, MATASHA | — |
| 17915689 | METHOD FOR SELECTING CELLS EXPRESSING A NUCLEIC ACID OF INTEREST | WESTON, ALYSSA G | — |
| 17913649 | TRBC BETA ANTIBODY CONJUGATE | GANGLE, BRIAN J | — |
| Art Unit | Apps |
|---|---|
| 1633 | 2 |
| 1672 | 1 |
| 1631 | 1 |
| 1635 | 1 |
| 1632 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18597357 | CHIMERIC ANTIGEN RECEPTOR | DUFFY, BRADLEY | — | DP | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18590698 | NUCLEIC ACID CONSTRUCT | KELLY, ROBERT M | — | §112 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18504554 | VECTORS | KINSEY WHITE, NICOLE ERIN | 1672 | §102§112DP | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18158310 | CELL | LEONARD, ARTHUR S | 1631 | §103 | Non-Final OA | 18d overdue | Pending | Jan 23, 2023 |
| 17924345 | METHOD | SHIN, DANA H | 1635 | §103Other | Final Rejection | — | Pending | Nov 09, 2022 |
| 17915637 | CELL | DHAR, MATASHA | 1632 | §103 | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17915689 | METHOD FOR SELECTING CELLS EXPRESSING A NUCLEIC ACID OF INTEREST | WESTON, ALYSSA G | 1633 | §102 | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17913649 | TRBC BETA ANTIBODY CONJUGATE | GANGLE, BRIAN J | 1645 | §112 | Final Rejection | — | Pending | Sep 22, 2022 |
| 17436673 | COMPOSITIONS AND METHODS COMPRISING ENGINEERED CHIMERIC ANTIGEN RECEPTOR AND MODULATOR OF CAR | WESTON, ALYSSA G | 1633 | §102 | Final Rejection | — | Pending | Sep 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial